Revenue: The sum of all revenue fields included for a company's operating activities.
Ascendis Pharma A/S (ASND) had Revenue of $106.36M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$106.36M |
$-99.69M |
|
$18.45M |
|
$87.90M |
|
$216.14M |
|
$-109.79M |
|
$11.22M |
|
$-98.57M |
|
$-98.57M |
|
$-99.69M |
|
$-99.69M |
|
$-99.69M |
|
$-99.69M |
|
$-109.79M |
|
$-105.00M |
|
60.02M |
|
60.02M |
|
$-1.67 |
|
$-1.67 |
|
| Balance Sheet Financials | |
$970.79M |
|
$97.39M |
|
$147.44M |
|
$1.12B |
|
$932.88M |
|
$376.43M |
|
$385.30M |
|
$1.32B |
|
$-199.96M |
|
$-204.08M |
|
$-199.96M |
|
60.37M |
|
| Cash Flow Statement Financials | |
$-15.08M |
|
$-0.74M |
|
$-18.99M |
|
$589.48M |
|
$545.63M |
|
$-43.85M |
|
$26.93M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.04 |
|
-- |
|
-- |
|
2.13 |
|
-4.46 |
|
82.65% |
|
-103.23% |
|
-103.23% |
|
-- |
|
-92.68% |
|
-93.73% |
|
$-15.82M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.06 |
|
1.31 |
|
68.49 |
|
49.85% |
|
48.85% |
|
-8.91% |
|
-56.49% |
|
$-3.31 |
|
$-0.26 |
|
$-0.25 |
|